Live feed16:06:02·1306dSECFilingvia QuantisnowBrooklyn ImmunoTherapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.BTX· BlackRock Technology and Private Equity Term TrustOriginal source